Ausgabe 8/2017
Inhalt (9 Artikel)
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders
Elisabeth I. Minder, Jasmin Barman-Aksoezen, Xiaoye Schneider-Yin
Renal Drug Transporters and Drug Interactions
Anton Ivanyuk, Françoise Livio, Jérôme Biollaz, Thierry Buclin
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Maud A. S. Weerink, Michel M. R. F. Struys, Laura N. Hannivoort, Clemens R. M. Barends, Anthony R. Absalom, Pieter Colin
Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment
Pamela L. Clemens, Xiaoyu Yan, Henk M. Lokhorst, Sagar Lonial, Nedjad Losic, Imran Khan, Richard Jansson, Tahamtan Ahmadi, Kristen Lantz, Honghui Zhou, Thomas Puchalski, Xu Steven Xu
Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn–Research–Confirm Process
Dongyang Liu, Yi Zhang, Ji Jiang, John Choi, Xuening Li, Dalong Zhu, Dawei Xiao, Yanhua Ding, Hongwei Fan, Li Chen, Pei Hu
Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus
Daniel Gonzalez, James M. Chamberlain, Jeffrey T. Guptill, Michael Cohen-Wolkowiez, Barrie Harper, Jian Zhao, Edmund V. Capparelli, Daniel K. Benjamin, Katherine Y. Berezny, Gregory L. Kearns, Matthew M. Laughon, Ian M. Paul, Michael J. Smith, P. Brian Smith, John van den Anker, Kelly Wade, David Siegel, Perdita Taylor-Zapata, Anne Zajicek, Zhaoxia Ren, Ekaterini Tsilou, Alice Pagan, Ravinder Anand, Traci Clemons, Gina Simone, Michael Cohen-Wolkowiez, Kevin Watt, Jeffrey T. Guptill, Barrie Harper, Daniel Gonzalez, Edmund V. Capparelli
Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma
Peggy Gandia, Cyril Jaudet, Hendrik Everaert, Johannes Heemskerk, Anne Marie Vanbinst, Johan de Mey, Johnny Duerinck, Bart Neyns, Mark de Ridder, Etienne Chatelut, Didier Concordet
A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach
Franc Andreu, Helena Colom, Laure Elens, Teun van Gelder, Ronald H. N. van Schaik, Dennis A. Hesselink, Oriol Bestard, Joan Torras, Josep M. Cruzado, Josep M. Grinyó, Nuria Lloberas
CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients
Daniel T. Barratt, Hannah K. Cox, Andrew Menelaou, David T. Yeung, Deborah L. White, Timothy P. Hughes, Andrew A. Somogyi